2-AMINO-4-(2,4,4-TRIMETHYLPENTAN-2-YL)PHENOL, 95%, 1g

5-(4-Bromo-2-methylphenyl)-1H-tetrazole, 97%, 250mg

6-Methyl-8-(methylthio)-3-[1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-4-yl]imidazo[1,2-a]pyrazine, 98%, 250mg

2-(3-METHYLPHENOXY)ETHANOL, 95%, 1g

5-methyl-1H-imidazole-4-carboxylic acid hydrochloride, 95.0%, 2.5g

Ossido di bismuto(III), minimo 99,5%, pa, 25 g, confezione in plastica.

(2E)-4-[(2,6-dimethylphenyl)amino]-4-oxobut-2-enoic acid, 1g

2,3,5-Trimethylaniline, 97%, 1g

1-Octadecyl-4-((1E,3E)-4-phenylbuta-1,3-dien-1-yl)pyridin-1-ium bromide, 97%, 1g

5-Methylpyridine-3,4-diamine, 95.0%, 250mg

Methyl 2,6-Dichloroisonicotinate, 97.0%, 10g

1-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroquinoline-7-carboxylic acid, 96%, 500mg

3-Bromo-2,2-dimethylpropanoyl fluoride, 5g